Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
Gemma Gatta(Fondazione IRCCS Istituto Nazionale dei Tumori), Alice Nennecke, Karri Seppä, Ladislav Dušek(Institute of Health Information and Statistics), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Aurélien Belot, Guy Launoy(Inserm), Daniela Pierannunzio(Istituto Superiore di Sanità), Andrea Eberle(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Jean Faivre(Institut de Cancérologie de Lorraine), Mario Šekerija(London Cancer), Gerda Engholm(National Board of Health and Welfare), Laura Botta(Fondazione IRCCS Istituto Nazionale dei Tumori), Marc Maynadié(Universidad de Granada), Pascale Grosclaude(Seoul National University Children's Hospital), Florence Molinié, Lisa Licitra(University of Milan), Hans H. Storm(Danish Cancer Society), Brigitte Trétarre(Pancreatic Cancer Action Network), K. Henau, Anne‐Sophie Woronoff, Alain Monnereau, Lesley Anderson(Queen's University Belfast), Michel Robaszkiewicz(Universidad de Granada), Nadine Bossard(Istituto Superiore di Sanità), Véronique Bouvier(Inserm), Tiiu Aareleid(Fondazione IRCCS Istituto Nazionale dei Tumori), Hermann Brenner(Universidad de Granada), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Z. Valerianova(Istituto Superiore di Sanità), Nea Malila(Istituto Superiore di Sanità), Miroslav Zvolský(Institute of Health Information and Statistics), Willi Oberaigner, María‐José Sánchez(Instituto de Investigación Biosanitaria de Granada), M. Meyer(Universidad de Granada), X. Troussard, B. Lapôtre‐Ledoux(Fondazione IRCCS Istituto Nazionale dei Tumori), Monika Hackl(Universidad de Granada), Roland Stabenow(Fondazione IRCCS Istituto Nazionale dei Tumori), P. Arveux(Istituto Superiore di Sanità), S. Bara(Fondazione IRCCS Istituto Nazionale dei Tumori), Sabine Luttmann(Fondazione IRCCS Istituto Nazionale dei Tumori), Michel Velten(Pancreatic Cancer Action Network), E. Van Eycken(Istituto Superiore di Sanità), Claire Schvartz(Fondazione IRCCS Istituto Nazionale dei Tumori), Isabelle Baldi(Pancreatic Cancer Action Network), A.V. Guizard, N. Zielonke(Istituto Superiore di Sanità)
Cited by 485
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k